Trexquant Investment LP Moderna, Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $9.03 Million - $14.9 Million	89,181 New	89,181 $10.6 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $5.31 Million - $6.97 Million	55,056 Added 375.35%	69,724 $7.2 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $14.2 Million - $19.3 Million	-119,919 Reduced 89.1%	14,668 $1.78 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $18.3 Million - $26.5 Million	134,587 New	134,587 $20.7 Million
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $5.86 Million - $8.84 Million	50,072 New	50,072 $7.15 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $5.3 Million - $9.85 Million	-41,922 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $6.94 Million - $11.3 Million	30,738 Added 274.84%	41,922 $10.6 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $2.14 Million - $4.66 Million	9,626 Added 617.84%	11,184 $4.3 Million
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $4.92 Million - $8.89 Million	-37,838 Reduced 96.05%	1,558 $366,000
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $1.29 Million - $2.2 Million	11,820 Added 42.86%	39,396 $5.16 Million
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $1.81 Million - $4.68 Million	27,576 New	27,576 $2.88 Million
Q3 2020 Nov 06, 2020	SELL	$54.34 - $94.85 $3.72 Million - $6.49 Million	-68,456 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$29.67 - $80.0 $2.03 Million - $5.48 Million	68,456 New	68,456 $4.4 Million
Q1 2020 May 08, 2020	SELL	$17.78 - $31.58 $422,915 - $751,161	-23,786 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$13.93 - $21.28 $331,338 - $506,166	23,786 New	23,786 $465,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account